All the points you've so far re the salvation of Ventracor are valid; except for one gigantic oversight.
In the past two years or so the company has been run into the ground despite paying top dollar/supposedly attracting the best in the business to get the company over the line. Their collective abyssmal performance is well documented. [just the fact that at one point in recent months a firm offer of 77c was made and this was never declared to the ASX...is typical of the disdain the management and the board regard the company's institutional and retail shareholders]
Gdavid and his colleagues have as yet indicated that they could manage the company any more effectively...but they do offer an alternative [and some hope, based on desperation] that Ventracor is deserving of another chance. The finish line is within sight; Crosby et.al. should not be there when this line is crossed as they are totally undeserving of any further personal financial gain from a medical device company in the development phase that they have exploited for their own purposes.
It's been 10 years in the making; let's stabilise the financials, get genuine management in [should be plenty around as senior management types are being layed off everywhere] and just maybe take another year or so to attain cost neutral status...it would be worth the wait.
VCR Price at posting:
9.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.